Minamo is an innovative medical technology company that develops new, patented surface technologies with antimicrobial properties for silicone medical devices. Our goal is to increase the safety of medical devices by preventing microorganisms from adhering to silicone surfaces and forming microbial coatings (biofilms). In this way, we want to address important challenges related to the hygiene of medical devices and contribute to the fight against antibiotic resistance.
The technology is based on research at the University of Iceland and represents a significant innovation in the surface treatment of silicone. Unlike traditional methods, Minamo's technology allows the formation of stable and durable antimicrobial coatings without the use of antibiotics, harmful additives or harsh surface activation methods. The coating can be applied using simple and scalable methods, such as spraying or dipping, which facilitates its integration into existing medical device manufacturing processes.
Minamo's technology is currently at TRL 5 and has demonstrated excellent antimicrobial activity, stability and durability, as well as excellent results in cell culture tests that assess the material's compatibility with cells. We are now working to bring the technology closer to the market through collaboration with medical device manufacturers.
Minamo's core technology is protected by a granted European patent and patent protection is being pursued in the United States, Japan and China, creating a strong foundation for international commercialization of the technology.
By combining powerful scientific research with practical manufacturing solutions, Minamo aims to transform the development and production of silicone medical devices and contribute to safer and more sustainable healthcare.







